547 related articles for article (PubMed ID: 26590574)
1. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
Yu Z; Li D; Ju XL
J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
4. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B.
Zhang F; Lu Y; Wang M; Zhu J; Li J; Zhang P; Yuan Y; Zhu F
Mol Cell Probes; 2020 Jun; 51():101513. PubMed ID: 31968218
[TBL] [Abstract][Full Text] [Related]
5. Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a.
Wu J; Zhang Y; Li X; Ren J; Chen L; Chen J; Cao Y
Biochem Biophys Res Commun; 2022 Sep; 622():149-156. PubMed ID: 35863089
[TBL] [Abstract][Full Text] [Related]
6. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
Diaz de la Guardia R; Lopez-Millan B; Lavoie JR; Bueno C; Castaño J; Gómez-Casares M; Vives S; Palomo L; Juan M; Delgado J; Blanco ML; Nomdedeu J; Chaparro A; Fuster JL; Anguita E; Rosu-Myles M; Menéndez P
Stem Cell Reports; 2017 Jun; 8(6):1573-1586. PubMed ID: 28528702
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia.
Zhang TJ; Guo H; Zhou JD; Li XX; Zhang W; Ma JC; Wen XM; Yao XY; Lin J; Qian J
Pathol Res Pract; 2018 Jan; 214(1):169-173. PubMed ID: 29254789
[TBL] [Abstract][Full Text] [Related]
8. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
[TBL] [Abstract][Full Text] [Related]
9. Bone Marrow Mesenchymal Stem Cells-Derived Exosomal miR-425-5p Inhibits Acute Myeloid Leukemia Cell Proliferation, Apoptosis, Invasion and Migration by Targeting WTAP.
Zhang L; Khadka B; Wu J; Feng Y; Long B; Xiao R; Liu J
Onco Targets Ther; 2021; 14():4901-4914. PubMed ID: 34594112
[TBL] [Abstract][Full Text] [Related]
10. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
11. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
[TBL] [Abstract][Full Text] [Related]
13. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia.
Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM
Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094
[TBL] [Abstract][Full Text] [Related]
14. [Bioinformatics Analysis and Verification of Aging-Related Genes of Bone Marrow Mesenchymal Stem Cells in Patients with Acute Myeloid Leukemia].
Liu SQ; Cheng JY; Jiang YJ; Li Y; Li QH; Pang TX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):311-317. PubMed ID: 30998131
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells.
Yuan Z; Wang W
Hematology; 2020 Dec; 25(1):160-164. PubMed ID: 32319862
[No Abstract] [Full Text] [Related]
16. [Immunomodulatory effects of mesenchymal stem cells derived from the bone marrow in acute leukemia patients].
Zhao ZG; Sun L; Wang XF; Zhang YZ; Yu Y; Yang HL; Zou P
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):105-9. PubMed ID: 21575477
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
18. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
[TBL] [Abstract][Full Text] [Related]
20. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]